| |
| |
|
| Insider
Information: |
Lyon Joseph Douglas |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
7,314 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$166,759 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,314 |
|
|
| Total
Value |
$166,759 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
|
2024-04-04 |
7,314 |
2021-02-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-04-04 |
4 |
AS |
$26.00 |
$141,524 |
D/D |
(5,443) |
7,314 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-04-04 |
4 |
OE |
$11.35 |
$61,778 |
D/D |
5,443 |
12,757 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-04-01 |
4 |
AS |
$26.01 |
$13,004 |
D/D |
(500) |
7,314 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-04-01 |
4 |
OE |
$11.35 |
$5,675 |
D/D |
500 |
7,814 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2024-03-01 |
4 |
D |
$24.06 |
$11,404 |
D/D |
(474) |
6,300 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$12,198 |
D/D |
1,014 |
7,314 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2024-02-16 |
4 |
AS |
$26.00 |
$26,000 |
D/D |
(1,000) |
6,774 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2024-02-16 |
4 |
OE |
$11.35 |
$11,350 |
D/D |
1,000 |
7,774 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-12-04 |
4 |
AS |
$26.00 |
$63,232 |
D/D |
(2,432) |
5,854 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-12-04 |
4 |
OE |
$11.35 |
$27,603 |
D/D |
2,432 |
8,286 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-12-01 |
4 |
OE |
$11.35 |
$29,147 |
D/D |
2,568 |
8,422 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-12-01 |
4 |
AS |
$26.00 |
$66,768 |
D/D |
(2,568) |
5,854 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-12-01 |
4 |
A |
$0.00 |
$11,946 |
D/D |
920 |
6,774 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-10-06 |
4 |
AS |
$27.24 |
$70,334 |
D/D |
(2,582) |
5,854 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-10-06 |
4 |
OE |
$11.35 |
$29,306 |
D/D |
2,582 |
8,436 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-10-02 |
4 |
AS |
$27.25 |
$65,889 |
D/D |
(2,418) |
5,854 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-10-02 |
4 |
OE |
$11.35 |
$27,444 |
D/D |
2,418 |
8,272 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-09-01 |
4 |
A |
$0.00 |
$11,949 |
D/D |
722 |
5,854 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-09-01 |
4 |
S |
$32.73 |
$163,650 |
D/D |
(5,000) |
5,132 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-09-01 |
4 |
OE |
$11.35 |
$56,750 |
D/D |
5,000 |
10,132 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-08-21 |
4 |
S |
$31.19 |
$143,100 |
D/D |
(4,588) |
5,132 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-08-21 |
4 |
OE |
$8.27 |
$40,508 |
D/D |
4,588 |
9,720 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-08-07 |
4 |
OE |
$8.27 |
$3,407 |
D/D |
412 |
5,132 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-08-07 |
4 |
S |
$31.22 |
$12,863 |
D/D |
(412) |
4,720 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-06-06 |
4 |
OE |
$11.35 |
$113,500 |
D/D |
10,000 |
15,132 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
